Global Bipolar Disorder Market By Type of Bipolar Disorder( Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder, Rapid Cycling Bipolar, Bipolar with Mixed Features, Bipolar with Seasonal Pattern, Unspecified Bipolar) By Treatment Type (Medications (Anti-Anxiety Medications, Antipsychotic Drugs, Antidepressants, Sleeping Pills, Mood Stabilizer) Psychotherapy (Interpersonal and Social Rhythm Therapy (IPSRT), Cognitive Behavioral Therapy (CBT), Psychoeducation, Family-focused Therapy) Electroconvulsive Therapy (ECT), Transcranial Magnetic Stimulation (TMS), Others) By Age Group (Children and Adolescents, Adults, Geriatric) By Sales Channel (Hospitals and Clinics, Retail Pharmacies, Online Pharmacies, Therapy Centers) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2023 – 2031